Cita APA

Tanaka, A., & Node, K. (2017). Increased amputation risk with canagliflozin treatment: Behind the large cardiovascular benefit? Cardiovasc Diabetol.

Chicago Style Citation

Tanaka, Atsushi, i Koichi Node. "Increased Amputation Risk With Canagliflozin Treatment: Behind the Large Cardiovascular Benefit?" Cardiovasc Diabetol 2017.

Cita MLA

Tanaka, Atsushi, i Koichi Node. "Increased Amputation Risk With Canagliflozin Treatment: Behind the Large Cardiovascular Benefit?" Cardiovasc Diabetol 2017.